Acute angiotensin-converting enzyme inhibition evokes bradykinin-induced sympathetic activation in diabetic rats
Authors:
Open Access
- 1 December 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 293 (6) , R2260-R2266
Abstract
We have previously shown that acute intravenous injection of the angiotensin-converting enzyme (ACE) inhibitor enalapril in diabetic rats evokes a baroreflex-independent sympathoexcitatory effect that does not occur with angiotensin receptor blockade alone. As ACE inhibition also blocks bradykinin degradation, we sought to determine whether bradykinin mediated this effect. Experiments were performed in conscious male Sprague-Dawley rats, chronically instrumented to measure mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA), 2 wk after streptozotocin (55 mg/kg iv, diabetic, n = 11) or citrate vehicle (normal, n = 10). Enalapril (2.5 mg/kg iv) decreased MAP in normal rats (−15 ± 3 mmHg), while a smaller response (−4 ± 1 mmHg) occurred in diabetic rats. Despite these different depressor responses to enalapril, HR (+44 ± 8 vs. +26 ± 7 bpm) and RSNA (+90 ± 21 vs +71 ± 8% baseline) increased similarly between the groups ( P ≥ 0.22 for both). Pretreatment with the bradykinin B2 receptor antagonist Hoe 140 (10 μg/kg bolus followed by 0.8·μg−1kg·min−1 infusion) attenuated the decrease in MAP observed with enalapril in normal rats but had no effect in diabetic rats. Moreover, the normal group had smaller HR and RSNA responses (HR: +13 ± 8 bpm; RSNA: +32 ± 13% baseline) that were abolished in the diabetic group (HR: −4 ± 5 bpm; RSNA: −5 ± 9% baseline; P < 0.05 vs. preenalapril values). Additionally, bradykinin (20 μg/kg iv) evoked a larger, more prolonged sympathoexcitatory effect in diabetic compared with normal rats that was further potentiated after treatment with enalapril. We conclude that enhanced bradykinin signaling mediates the baroreflex-independent sympathoexcitatory effect of enalapril in diabetic rats.Keywords
This publication has 22 references indexed in Scilit:
- Potentiation of Bradykinin Effect by Angiotensin-Converting Enzyme Inhibition Does Not Correlate With Angiotensin-Converting Enzyme Activity in the Rat Mesenteric ArteriesHypertension, 2007
- Expression and distribution of kinin B1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocinSynapse, 2005
- Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive ratsBritish Journal of Pharmacology, 2004
- Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in MiceHypertension, 2004
- Effect of Bradykinin-Receptor Blockade on the Response to Angiotensin-Converting–Enzyme Inhibitor in Normotensive and Hypertensive SubjectsNew England Journal of Medicine, 1998
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994
- Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudiesBritish Journal of Pharmacology, 1991
- The central pressor effect of bradykinin in normotensive and hypertensive rats.Hypertension, 1988
- Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitusJournal of the Autonomic Nervous System, 1987
- Role of prostaglandins and the areas postrema in the central pressor action of bradykininEuropean Journal of Pharmacology, 1985